Investor Announcements - 2013

Interim results

16^th Sep 2013

EKF Diagnostics Holdings plc announces its unaudited interim results for the six months ended 30 June 2013.

Final results for the year ended 31 December 2012

18^th Mar 2013

Final results for the year ended 31 December 2012.

Establishment of EKF Molecular Diagnostics & Acquisition of 360 Genomics Limited

4^th Mar 2013

EKF Diagnostics announces that it has established a new subsidiary, EKF Molecular Diagnostics Limited (“EKF Molecular”), to focus on molecular and companion diagnostics.

Archive

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

Reliable Point-of-Care lactate analysis in cattle

Measuring lactate concentrations in cattle has been shown to be incredibly useful. This article discusses new methods available to farmers and veterinarians to get fast and reliable results without leaving the animal’s side.

EKF at Algeria Health - December 2018

Visit EKF Diagnostics at the largest healthcare event in the MAGHREB region. Algeria Health will be held on 5-8 December 2018 at the Palais des Expositions, Algiers.

EKF launches pocket-sized lactate monitor for sports performance monitoring at MEDICA 2018

EKF Diagnostics will be launching its new Lactate Scout 4 hand-held lactate analyzer for fast and accurate sports performance monitoring. Lactate Scout 4 is designed for use in the field as a training companion for individuals or sports teams, and will be demonstrated to delegates attending the co-located MEDICA MEDICINE + SPORTS conference.

EKF at MEDICA - November 2018

MEDICA is the world’s largest medical trade fair. For more than 40 years it has been firmly established on every expert’s calendar attracting over 40,000 delegates and over 5,000 exhibitors from 70 countries in 17 halls.

HbA1c testing at the point-of-care: Comparison against international quality standards